Morton Toe and Neuromuscular Performance
Morton Toe is Associated With Faster Contractile Properties and Superior Reactive Strength in Female Football Players
Panoramica dello studio
Stato
Condizioni
Descrizione dettagliata
Morton toe is a congenital foot morphology characterized by a longer second metatarsal relative to the first. Although traditionally regarded as a clinical or orthopedic variation associated with metatarsal stress fractures and balance difficulties, limited evidence from sprinter populations suggests that a longer second toe may be associated with superior athletic performance. However, no previous study has examined whether Morton toe morphology is related to neuromuscular contractile properties assessed via tensiomyography or kinetic performance derived from force plate testing in a controlled group comparison design.
Participants were screened from 97 female football players. Exclusion criteria included BMI outside the 18.5-29.9 range, bilateral arch index outside the 14-29% range, inconsistent bilateral foot morphology, lower-extremity injury within the past 12 months, neurological or orthopedic conditions, performance-affecting pharmacological use, and menstruation on the measurement day. Morton toe classification was based on the palpation method described by Davidson et al. (2007) with a minimal detectable change threshold of ±0.30 mm.
All measurements were conducted during the off-season to minimize training load interference. Testing followed a standardized sequence: foot morphology assessment, tensiomyography of the dominant vastus lateralis at rest, a 15-minute warm-up, and a 40-cm drop jump test. The assessor was blinded to group classification, and statistical analysis was performed by an independent researcher on a coded dataset. Primary outcome variables (Tc and RSI) were determined a priori. Secondary outcomes were corrected for multiple comparisons using the Holm-Bonferroni method. Regression analyses were performed to assess the independence of group effects from age, body mass index, and mean bilateral arch index.
Tipo di studio
Iscrizione (Effettivo)
Contatti e Sedi
Luoghi di studio
-
-
Centre
-
Giresun, Centre, Turchia (Türkiye), 28100
- Giresun University - Sports Science Faculty
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
- Adulto
- Adulto più anziano
Accetta volontari sani
Metodo di campionamento
Popolazione di studio
Descrizione
Inclusion Criteria:
- Active female football players with a valid sports license for the current season
- Regular participation in training and competitive matches
- Bilateral Morton toe morphology (Δ ≤ -0.30 mm on both feet) or bilateral normal foot morphology (Δ > +0.30 mm on both feet)
- Body mass index between 18.5 and 29.9 kg/m²
- Bilateral arch index between 14% and 29%
- Voluntary participation with written informed consent
Exclusion Criteria:
- Serious lower-extremity musculoskeletal injury within the past 12 months
- Neurological or orthopedic disease affecting measurement procedures
- Current use of pharmacological products affecting performance
- Acute pain, injury, or illness on the measurement day
- Menstruation on the measurement day (self-reported)
- Inconsistent bilateral foot morphology classification between feet
- Bilateral arch index below 14% (high arch) or above 29% (low arch)
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
Coorti e interventi
Gruppo / Coorte |
|---|
|
Morton Foot Group
Female football players with bilateral Morton toe morphology, defined as a second metatarsal protrusion distance exceeding the first by more than 0.30 mm bilaterally (Δ ≤ -0.30 mm).
n = 24.
|
|
Normal Foot Group
Female football players with bilateral normal foot morphology, defined as a first metatarsal protrusion distance exceeding the second by more than 0.30 mm bilaterally (Δ > +0.30 mm).
n = 23.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Contraction Time (Tc)
Lasso di tempo: Single measurement session
|
Tensiomyographic contraction time of the dominant vastus lateralis muscle, defined as the time between 10% and 90% of maximal radial displacement (ms).
|
Single measurement session
|
|
Reactive Strength Index (RSI)
Lasso di tempo: Single measurement session
|
Jump height divided by ground contact time during a 40-cm drop jump test (m/s).
The trial with the highest RSI value out of three attempts was selected for analysis.
|
Single measurement session
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Maximal Displacement (Dm)
Lasso di tempo: Single measurement session
|
Peak radial displacement of the vastus lateralis muscle belly during tensiomyographic measurement (mm).
|
Single measurement session
|
|
Relaxation Time (Tr)
Lasso di tempo: Single measurement session
|
Time from 90% to 50% of maximal displacement during the relaxation phase of tensiomyographic measurement (ms).
|
Single measurement session
|
|
Delay Time (Td)
Lasso di tempo: Single measurement session
|
Time from electrical stimulus onset to 10% of maximal displacement during tensiomyographic measurement (ms).
|
Single measurement session
|
|
Sustain Time (Ts)
Lasso di tempo: Single measurement session
|
Duration the muscle response remains above 50% of maximal displacement during tensiomyographic measurement (ms).
|
Single measurement session
|
|
Jump Height (JH)
Lasso di tempo: Single measurement session
|
Vertical jump height calculated from flight time during a 40-cm drop jump test (cm).
|
Single measurement session
|
|
Peak Power Normalized to Body Mass (PPI)
Lasso di tempo: Single measurement session
|
Peak power output normalized to body mass during a 40-cm drop jump test (W/kg).
|
Single measurement session
|
|
Landing Net Peak Force Normalized to Body Mass (LPF)
Lasso di tempo: Single measurement session
|
Peak vertical ground reaction force at landing normalized to body mass during a 40-cm drop jump test (N/kg).
|
Single measurement session
|
Collaboratori e investigatori
Sponsor
Studiare le date dei record
Studia le date principali
Inizio studio (Effettivo)
Completamento primario (Effettivo)
Completamento dello studio (Effettivo)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Termini MeSH pertinenti aggiuntivi
Altri numeri di identificazione dello studio
- GRU-SBF-NS-06
- 10/492 (Altro identificatore: Giresun University Social Sciences, Natural Sciences and Engineering Research Ethics Committee)
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .
Prove cliniche su Foot Morphology
-
The General Authority for Teaching Hospitals and...ReclutamentoGestione | Denis Brawn Brace | Modifica | Foot club idiopatico | Casting PonsetiEgitto